248 related articles for article (PubMed ID: 26501952)
1. A qPCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells.
Tsankov AM; Akopian V; Pop R; Chetty S; Gifford CA; Daheron L; Tsankova NM; Meissner A
Nat Biotechnol; 2015 Nov; 33(11):1182-92. PubMed ID: 26501952
[TBL] [Abstract][Full Text] [Related]
2. Characterizing Pluripotent Stem Cells Using the TaqMan® hPSC Scorecard(TM) Panel.
Fergus J; Quintanilla R; Lakshmipathy U
Methods Mol Biol; 2016; 1307():25-37. PubMed ID: 25138722
[TBL] [Abstract][Full Text] [Related]
3. Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells.
International Stem Cell Initiative
Nat Commun; 2018 May; 9(1):1925. PubMed ID: 29765017
[TBL] [Abstract][Full Text] [Related]
4. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
5. A High Proliferation Rate is Critical for Reproducible and Standardized Embryoid Body Formation from Laminin-521-Based Human Pluripotent Stem Cell Cultures.
Dziedzicka D; Markouli C; Barbé L; Spits C; Sermon K; Geens M
Stem Cell Rev Rep; 2016 Dec; 12(6):721-730. PubMed ID: 27544201
[TBL] [Abstract][Full Text] [Related]
6. Confined 3D microenvironment regulates early differentiation in human pluripotent stem cells.
Giobbe GG; Zagallo M; Riello M; Serena E; Masi G; Barzon L; Di Camillo B; Elvassore N
Biotechnol Bioeng; 2012 Dec; 109(12):3119-32. PubMed ID: 22674472
[TBL] [Abstract][Full Text] [Related]
7. Efficient differentiation of newly derived human embryonic stem cells from discarded blastocysts into hepatocyte-like cells.
Lu H; Wang Z; Zheng Q; Li JH; Chong XQ; Xiao SD
J Dig Dis; 2010 Dec; 11(6):376-82. PubMed ID: 21091901
[TBL] [Abstract][Full Text] [Related]
8. Functional assays for human embryonic stem cell pluripotency.
O'Connor MD; Kardel MD; Eaves CJ
Methods Mol Biol; 2011; 690():67-80. PubMed ID: 21042985
[TBL] [Abstract][Full Text] [Related]
9. Spatial pattern dynamics of 3D stem cell loss of pluripotency via rules-based computational modeling.
White DE; Kinney MA; McDevitt TC; Kemp ML
PLoS Comput Biol; 2013; 9(3):e1002952. PubMed ID: 23516345
[TBL] [Abstract][Full Text] [Related]
10. Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods-A Systematic Review.
Montilla-Rojo J; Bialecka M; Wever KE; Mummery CL; Looijenga LHJ; Roelen BAJ; Salvatori DCF
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835305
[TBL] [Abstract][Full Text] [Related]
11. Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing.
Han X; Chen H; Huang D; Chen H; Fei L; Cheng C; Huang H; Yuan GC; Guo G
Genome Biol; 2018 Apr; 19(1):47. PubMed ID: 29622030
[TBL] [Abstract][Full Text] [Related]
12. Trisomy 12 compromises the mesendodermal differentiation propensity of human pluripotent stem cells.
Yanagihara K; Hayashi Y; Liu Y; Yamaguchi T; Hemmi Y; Kokunugi M; Yamada KU; Fukumoto K; Suga M; Terada S; Nikawa H; Kawabata K; Furue M
In Vitro Cell Dev Biol Anim; 2024 May; 60(5):521-534. PubMed ID: 38169039
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk.
Smith AJ; Nelson NG; Oommen S; Hartjes KA; Folmes CD; Terzic A; Nelson TJ
Stem Cells Transl Med; 2012 Oct; 1(10):709-18. PubMed ID: 23197662
[TBL] [Abstract][Full Text] [Related]
14. Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays.
Bouma MJ; van Iterson M; Janssen B; Mummery CL; Salvatori DCF; Freund C
Stem Cell Reports; 2017 May; 8(5):1340-1353. PubMed ID: 28494940
[TBL] [Abstract][Full Text] [Related]
15. Reconsidering pluripotency tests: do we still need teratoma assays?
Buta C; David R; Dressel R; Emgård M; Fuchs C; Gross U; Healy L; Hescheler J; Kolar R; Martin U; Mikkers H; Müller FJ; Schneider RK; Seiler AE; Spielmann H; Weitzer G
Stem Cell Res; 2013 Jul; 11(1):552-62. PubMed ID: 23611953
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome dynamics of human pluripotent stem cell-derived contracting cardiomyocytes using an embryoid body model with fetal bovine serum.
Jung KB; Son YS; Lee H; Jung CR; Kim J; Son MY
Mol Biosyst; 2017 Jul; 13(8):1565-1574. PubMed ID: 28671202
[TBL] [Abstract][Full Text] [Related]
17. Quantification of biomass and cell motion in human pluripotent stem cell colonies.
Zangle TA; Chun J; Zhang J; Reed J; Teitell MA
Biophys J; 2013 Aug; 105(3):593-601. PubMed ID: 23931307
[TBL] [Abstract][Full Text] [Related]
18. Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells.
Ditadi A; Sturgeon CM
Methods; 2016 May; 101():65-72. PubMed ID: 26439174
[TBL] [Abstract][Full Text] [Related]
19. Establishment of clinically compliant human embryonic stem cells in an autologous feeder-free system.
Fu X; Toh WS; Liu H; Lu K; Li M; Cao T
Tissue Eng Part C Methods; 2011 Sep; 17(9):927-37. PubMed ID: 21561302
[TBL] [Abstract][Full Text] [Related]
20. Superior Red Blood Cell Generation from Human Pluripotent Stem Cells Through a Novel Microcarrier-Based Embryoid Body Platform.
Sivalingam J; Lam AT; Chen HY; Yang BX; Chen AK; Reuveny S; Loh YH; Oh SK
Tissue Eng Part C Methods; 2016 Aug; 22(8):765-80. PubMed ID: 27392822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
